Skip to main content
Clinical Trials/NCT06061224
NCT06061224
Recruiting
Not Applicable

The Influences of Duration and Intensity of Early Mobilization on Myokines, Body Composition and Outcomes of Septic Patients in Intensive Care Unit

Chang Gung Memorial Hospital1 site in 1 country600 target enrollmentJanuary 1, 2022
ConditionsSepsis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sepsis
Sponsor
Chang Gung Memorial Hospital
Enrollment
600
Locations
1
Primary Endpoint
Hospital mortality
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

the investigators' preliminary data revealed that early physical therapy in patients with sepsis in ICU could promote recovery of function (liver and kidney) and decrease the length of stay in hospitalization. The levels of plasma IL-6 and IL-10 were higher in non-survival group than in survival group. the investigators hypothesize that myokines and body composition parameters are related to the prognosis of sepsis.the investigators will investigate the influences of duration and intensity of early mobilization on myokines, body composition and outcomes of septic patients in intensive care. The proposed study can help precision medicine in the future.

Detailed Description

The septic patients admitted to the intensive care unit (ICU) will be divided into three groups. One is non-PT group, with no physical treatment intervention (group 1), Early-PT group with physical treatment intervention started in ICU admission day 3 (group 2), and Delayed-PT with physical treatment intervention started after ICU admission day 3 (group 3). The grouping will be based on clinical indication for early mobilization (physical therapy) as below. The body composition data (of day 1, 3, 8) of the patients in the three groups will be measured, and the residual blood from day 1 and day 8 will be collected for detecting myokines.

Registry
clinicaltrials.gov
Start Date
January 1, 2022
End Date
September 30, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Chang Gung Memorial Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Aadmission in ICU
  • Clinical diagnosis of sepsis

Exclusion Criteria

  • Expired in 3-days
  • Cardiac stents or pacemakers
  • Airborne disease
  • Contact-transmitted disease

Outcomes

Primary Outcomes

Hospital mortality

Time Frame: The day discharged from hospital, "through study completion, an average of 1 year".

Status of survival or mortality at the time discharged from hospital

Change of percentage of body fat between day 1 and day 8

Time Frame: Day 1 and Day 8 after ICU admission

assessing the change of percentage of body fat between day 1 and day 8 by noninvasively Bio-electrical Impedance Analysis (BIA)

Change of total body water between day 1 and day 8

Time Frame: Day 1 and Day 8 after ICU admission

assessing the change of total body water between day 1 and day 8 by noninvasively Bio-electrical Impedance Analysis (BIA)

7-day mortality

Time Frame: Day 7 after hospital admission

Status of survival or mortality at Day 7 during hospital stay

28-day mortality

Time Frame: Day 28 after hospital admission

Status of survival or mortality at Day 28 during hospital stay

90-day mortality

Time Frame: Day 90 after hospital admission

Status of survival or mortality at Day 90 during hospital stay

Change of soft lean mass between day 1 and day 8

Time Frame: Day 1 and Day 8 after ICU admission

assessing the change of soft lean mass between day 1 and day 8 by noninvasively Bio-electrical Impedance Analysis (BIA)

Concentration of serum BDNF change between day 1 and day 8

Time Frame: Day 1 and Day 8 after ICU admission

assessing the change of serum BDNF between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)

Concentration of serum IL-15 change between day 1 and day 8

Time Frame: Day 1 and Day 8 after ICU admission

assessing the change of serum IL-15 between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)

ICU mortality

Time Frame: The day discharged from ICU, "through study completion, an average of 1 year".

Status of survival or mortality at the time discharged from ICU

ICU Days

Time Frame: During hospitalization, "through study completion, an average of 1 year".

length of ICU stay

Change of white blood cell between day 1 and day 8

Time Frame: Day 1 and Day8 after ICU admission

assessing the change of white blood cell count between day 1 and day 8

Concentration of serum Irisin change between day 1 and day 8

Time Frame: Day 1 and Day 8 after ICU admission

assessing the change of serum Irisin between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)

Ventilation days

Time Frame: During hospitalization, "through study completion, an average of 1 year".

Total using days of mechanical ventilation

Concentration of serum IL-6 change between day 1 and day 8

Time Frame: Day 1 and Day 8 after ICU admission

assessing the change of IL-6 between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)

Concentration of serum SPARC change between day 1 and day 8

Time Frame: Day 1 and Day 8 after ICU admission

assessing the change of serum SPARC (secreted protein acidic and rich in cysteine) between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)

Concentration of serum Myostatin change between day 1 and day 8

Time Frame: Day 1 and Day 8 after ICU admission

assessing the change of serum Myostatin between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)

Study Sites (1)

Loading locations...

Similar Trials